Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009RICHTER, Sandra S; HEILMANN, Kristopher P; DOHRN, Cassie L et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 4154-4160, issn 0066-4804, 7 p.Article

Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of FaropenemCRITCHLEY, Ian A; JACOBS, Michael R; BROWN, Steven D et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2639-2643, issn 0066-4804, 5 p.Article

Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07 : laboratory-based surveillance studyTILLOTSON, Glenn S; DRAGHI, Deborah C; SAHM, Daniel F et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 1, pp 109-115, issn 0305-7453, 7 p.Article

Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strainsJONES, Ronald N; CRITCHLEY, Ian A; WHITTINGTON, William L. H et al.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 4, pp 311-317, issn 0732-8893, 7 p.Article

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the Trust Surveillance Program (1998-2002)KARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 8, pp 963-970, issn 1058-4838, 8 p.Article

National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance StudyCRITCHLEY, Ian A; BROWN, Steven D; TRACZEWSKI, Maria M et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 12, pp 4382-4389, issn 0066-4804, 8 p.Article

In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-Negative bacilliCRITCHLEY, Ian A; SAHM, Daniel F; KELLY, Laurie J et al.Chemotherapy (Basel). 2003, Vol 49, Num 1-2, pp 44-48, issn 0009-3157, 5 p.Article

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaFILE, Thomas M; LOW, Donald E; ECKBURG, Paul B et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, issn 0305-7453, iii19-iii32, SUP3Article

Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and IsraelSTONE, Kimberley Clawson; DAGAN, Ron; ARGUEDAS, Adriano et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2230-2235, issn 0066-4804, 6 p.Article

Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetaseOCHSNER, Urs A; YOUNG, Casey L; STONE, Kimberley C et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4253-4262, issn 0066-4804, 10 p.Article

Longitudinal assessment of antipneumococcal susceptibility in the United StatesJONES, Mark E; KARLOWSKY, James A; BLOSSER-MIDDLETON, Renée et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2651-2655, issn 0066-4804Article

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S; JONES, Mark E et al.International journal of antimicrobial agents. 2002, Vol 20, Num 2, pp 100-107, issn 0924-8579, 8 p.Article

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States : 2-year longitudinal analysisSAHM, Daniel F; KARLOWSKY, James A; KELLY, Laurie J et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 4, pp 1037-1042, issn 0066-4804Article

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaLOW, Donald E; FILE, Thomas M; ECKBURG, Paul B et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, issn 0305-7453, iii33-iii44, SUP3Article

Antibacterial activity of REP8839, a new antibiotic for topical useCRITCHLEY, Ian A; YOUNG, Casey L; STONE, Kimberley C et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4247-4252, issn 0066-4804, 6 p.Article

Activity of cefditoren against β-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalisKARLOWSKY, James A; CRITCHLEY, Ian A; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 53-58, issn 0732-8893Article

Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strainKARLOWSKY, James A; CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 3, pp 1063-1066, issn 0095-1137Article

Determining linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national releaseKARLOWSKY, James A; KELLY, Laurie J; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1989-1992, issn 0066-4804Article

Regional trends in antimicrobial Resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST surveillance program, 1999-2000THORNSBERRY, Clyde; SAHM, Daniel F; KELLY, Laurie J et al.Clinical infectious diseases. 2002, Vol 34, pp S4-S16, issn 1058-4838, SUP1Article

Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United StatesJACOBS, Michael R; GOOD, Caryn E; WINDAU, Anne R et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2716-2719, issn 0066-4804, 4 p.Article

Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection modelOCHSNER, Urs A; BELL, Stacie J; O'LEARY, Ann L et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 5, pp 964-971, issn 0305-7453, 8 p.Article

Baseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000-2001CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S; JONES, Mark E et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1689-1693, issn 0066-4804, 5 p.Article

Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: Results from 2000-2001 and 2001-2002 TRUST studies in the United StatesKARLOWSKY, James A; THORNSBERRY, Clyde; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 6, pp 1790-1797, issn 0066-4804, 8 p.Article

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999CRITCHLEY, Ian A; SAHM, Daniel F; THORNSBERRY, Clyde et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 2, pp 129-135, issn 0732-8893Article

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.International journal of antimicrobial agents. 2002, Vol 19, Num 1, pp 21-31, issn 0924-8579Article